Zusammenfassung
AIDS ist eine der wesentlichen Bedrohungen für die Menschheit unter den heutigen Infektionskrankheiten. Die Krankheit verursacht weltweit Millionen Todesfälle jährlich.
Article PDF
References
Altmann A, Däumer M, Beerenwinkel N, Peres Y, Schülter E, Buch J, Rhee SY, Sönnerborg A, Fessel WJ, Shafer RW, Zazzi M, Kaiser R, Lengauer T (2009) Predicting the response to combination antiretroviral therapy: Retrospective validation of geno2pheno-THEO on a large clinical database. J Infect Dis 199(7):999–1006
Beerenwinkel N, Schmidt B, Walter H, Kaiser R, Lengauer T, Hoffmann D, Korn K, Selbig J (2002) Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proc Natl Acad Sci USA 99(12):8271–8276
Beerenwinkel N, Däumer M, Oette M, Korn K, Hoffmann D, Kaiser R, Lengauer T, Selbig J, Walter H (2003) Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res 31(13):3850–3855
Beerenwinkel N, Sing T, Lengauer T, Rahnenführer J, Roomp K, Savenkov I, Fischer R, Hoffmann D, Selbig J, Korn K, Walter H, Berg T, Braun P, Fätkenheuer G, Oette M, Rockstroh J, Kupfer B, Kaiser R, Däumer M (2005) Computational methods for the design of effective therapies against drug resistant HIV strains. Bioinformatics 21(21):3943–3950
Beerenwinkel N, Däumer M, Sing T, Rahnenführer J, Lengauer T, Selbig J, Hoffmann D, Kaiser R (2005) Estimating HIV evolutionary pathways and the genetic barrier to drug resistance. J Infect Dis 191(11):1953–1960
Beerenwinkel N, Rahnenführer J, Däumer M, Hoffmann D, Kaiser R, Selbig J, Lengauer T (2005) Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol 12(6):584–598
Bickel S, Bogojeska J, Lengauer T, Scheffer T (2008) Multi-task learning for HIV therapy screening. In: McCallum A, Roweis S (eds) 25th International Conference on Machine Learning (ICML 2008). Omnipress, Helsinki, pp 56–63
Breiman L (2001) Random forests. Mach Learn 45(1):5–32
Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD (2008) Update of the drug resistance mutations in HIV-1: Spring 2008. Top HIV Med 16(1):62–68
Lengauer T, Sing T (2006) Bioinformatics-assisted anti-HIV therapy. Nat Rev Microbiol 4(10):790–797
Modrow S, Falke D, Truyen U (2003) Molekulare Virologie, 2. Aufl. Spektrum Akademischer Verlag, Heidelberg Berlin
Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 31(1):298–303
Roomp K, Beerenwinkel N, Sing T, Schülter E, Büch J, Sierra-Aragon S, Däumer M, Hoffmann D, Kaiser R, Lengauer T, Selbig J (2006) Arevir: A secure platfrom for designing personalized antiretroviral therapies against HIV. In: Third International Workshop on Data Integration in the Life Sciences (DILS 2006). Springer, Hinxton
Rosen-Zvi M, Altmann A, Prosperi M, Aharoni E, Neuvirth H, Sönnerborg A, Schülter E, Struck D, Peres Y, Incardona F, Kaiser R, Zazzi M, Lengauer T (2008) Selecting anti-HIV therapies based on a variety of genomic and clinical factors. Bioinformatics 24(13):399–406
Sander O, Sing T, Sommer I, Low AJ, Cheung PK, Harrigan PR, Lengauer T, Domingues FS (2007) Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS Comput Biol 3(3):e58
Sing T, Däumer M (2006) Interpretation algorihms. In: Geretti M (ed) Antiretroviral resistance in clinical practice. Medscript, London, pp 43–56
Sing T, Low AJ, Beerenwinkel N, Sander O, Cheung PK, Domingues FS, Büch J, Däumer M, Kaiser D, Lengauer T, Harrigan PR (2007) Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antiviral Therapy 12(7):1097–1106
Svicher V, Sing T, Santoro MM, Forbici F, Rodriguez-Barrios F, Bertoli A, Beerenwinkel N, Bellocchi MC, Gago F, d’Arminio Monforte A, Antinori A, Lengauer T, Ceccherini-Silberstein F, Perno CF (2006) Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. J Virol 80(14):7186–7198
Walter H, Schmidt B, Korn K, Vandamme AM, Harrer T, Überla K (1999) Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. J Clin Virol 13(1–2):71–80
Wolf K, Walter H, Beerenwinkel N, Keulen W, Kaiser R, Hoffmann D, Lengauer T, Selbig J, Vandamme AM, Korn K, Schmidt B (2003) Tenofovir resistance and resensitization. Antimicrob Agents Chemother 47(11):3478–3484
http://www.euresist.org, letzter Aufruf: 18.5.2009
http://www.genafor.de, letzter Aufruf: 18.5.2009
http://www.geno2pheno.org, letzter Aufruf: 18.5.2009
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Lengauer, T., Altmann, A. & Thielen, A. Bioinformatische Unterstützung der Auswahl von HIV-Therapien. Informatik Spektrum 32, 320–331 (2009). https://doi.org/10.1007/s00287-009-0352-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00287-009-0352-7